B
BRNS
Barinthus Biotherapeutics plc
0.5410
-0.0276-4.85%After Hours: 0.5410 0.0000 0.00%19:51 04/07 EDT
OPEN/PREV CLOSE0.5700/0.5686
TODAY RANGE0.5400-0.6160
VOL20.92K
MARKET CAP22.10M
52 WEEK RANGE0.5120-2.920
AVG VOL (3M)44.81K
% TURNOVER0.05%
TURNOVER--
P/E (TTM)-0.3301
% RANGE13.37%
EPS(TTM)-1.6391
P/E(FORWARD)-0.3810
P/B0.2978
BVPS1.817
DIVIDEND--
P/S1.828
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP19.15M
SHARES OUTSTANDING40.85M
NEXT EARNINGS05/05-05/11
FREE FLOAT35.39M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/31 23:50
Barinthus Biotherapeutics Announces Upcoming Accounting Leadership Change
TipRanks·03/16 10:20
Wall Street Analysts Are Bullish on Top Healthcare Picks
Seeking Alpha·03/13 19:14
Barinthus Biotherapeutics GAAP EPS of -$1.64
TipRanks·03/13 12:28
Barinthus Bio Announces 2025 Results and Clywedog Merger
TipRanks·03/13 12:08
Barinthus Biotherapeutics reports FY25 EPS ($1.64) vs ($1.55) last year
Benzinga·03/13 12:07
Barinthus Biotherapeutics Q4 EPS $(0.27) Beats $(0.40) Estimate
Benzinga·03/13 12:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·03/10 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·02/23 11:32
Barinthus Biotherapeutics Amends Cross-Border Merger Agreement Terms
Benzinga·02/10 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·01/06 21:31
Barinthus Biotherapeutics Receives Nasdaq Minimum Bid Price Notice
TipRanks·12/11/2025 11:16
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
TipRanks·12/10/2025 13:28
Barinthus Biotherapeutics Updates on AVALON Trial Progress
Same Industry
Name/Symbol
Change%
Price